A retrospective cross-sectional study of side effects following COVID-19 vaccination in patients with inflammatory bowel disease in Japan
Latest Information Update: 04 Oct 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 04 Oct 2022 New trial record
- 30 Sep 2022 Results published in the Digestive Diseases and Sciences